alvionpharma.comCrawled Oct 25, 2026
Alvion’s 2026 product list includes generic and value-added medicines in Cardiology, CNS, Urology, Diabetes, and Oncology, with details on pharmaceutical form, strengths, and dossier status.
Alvion Pharmaceuticals offers out-licensing and supply, technical support, regulatory affairs and contract development services to partners across the global pharmaceutical industry.
Alvion Pharmaceuticals S.M.S.A. announces a strategic investment by iGrow Venture Partners VC, marking a milestone in its continued growth and international expansion.
Alvion Pharmaceuticals has completed the EU eCTD dossier of Ticagrelor film-coated tablets, a generic equivalent to Brilique, targeting first-to-market positioning in Europe.
Lupin Limited enters into a licensing agreement with Alvion Pharmaceuticals to commercialize cardiometabolic medicines across the Southeast Asia region.
Latest news from Alvion Pharmaceuticals — strategic investment, co-development milestones and first-to-market product announcements.
Alvion seeks professionals to advance its generics and value-added medicines.
Alvion is a private and independent pharmaceutical company focused on R&D, IP, Quality, Regulatory and manufacturing of generics and value-added medicines.
Alvion Pharmaceuticals is gradually becoming a global leader in the pharmaceutical industry — with licensing collaborations across Europe, MENA, LATAM, Canada, Australia, Africa and Asia.
Alvion Pharmaceuticals is a IP company focused in the development and manufacturing non infringing and difficult to make generic and added value medicines.
Alvion welcomes business opportunities with multinational and strong local pharmaceutical companies partnering via licensing agreements, co-development and pharmaceutical services.
Contact Alvion Pharmaceuticals to discuss licensing, partnership, regulatory and business development opportunities.
A science oriented pharmaceutical company Developing and manufacturing noninfringing generics and value-added medicines in Europe.
Alvion Pharmaceuticals outlines its privacy policy, including data processing, legal bases, safety reporting, and GDPR rights.
Alvion Pharmaceuticals is committed to fair and vigorous competition and full compliance with all applicable competition laws and regulations.